Loading…
Loading…
EQUITY / NASDAQ · XNMS
Aimei Health Technology Co., Ltd. Ordinary Share
01 / RESEARCH
8 financial reports are available for research.
Start research ↗12.11 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 12.11 USD · Volume 3,100
63 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Net income | -83,144 USD | 424,970 USD | -119.56% |
| Operating profit | -192,348 USD | -41,604 USD | — |
| Total assets | 12,532,359 USD | — | — |
| Total equity | -4,484,718 USD | -2,859,328 USD | — |
| Total liabilities | 4,528,684 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Net incomeIncome statement | -83,144 USD | -37,704 USD | 45,440 USD | — | 1,059,768 USD | 352,019 USD | 961,651 USD | 424,970 USD |
| Operating profitIncome statement | -192,348 USD | -254,332 USD | — | — | -835,759 USD | -130,152 USD | -585,170 USD | -41,604 USD |
| Total assetsBalance sheet | 12,532,359 USD | — | — | 12,103,039 USD | 12,103,039 USD | 45,468,518 USD | — | — |
| Total equityBalance sheet | -4,484,718 USD | — | -4,189,377 USD | -4,058,731 USD | -4,058,731 USD | -3,439,480 USD | — | -2,859,328 USD |
| Total liabilitiesBalance sheet | 4,528,684 USD | — | — | 4,061,660 USD | 4,061,660 USD | 3,464,428 USD | — | — |
| Financing cash flowCash flow statement | — | 401,705 USD | — | — | -63,040,145 USD | — | -29,391,161 USD | — |
| Investing cash flowCash flow statement | — | -171,655 USD | — | — | 63,579,966 USD | — | 29,887,800 USD | — |
| Operating cash flowCash flow statement | — | -231,513 USD | — | — | -565,100 USD | — | -521,868 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 05/04/2026 | Open report ↗ Published: 11/18/2025 | Open report ↗ Published: 11/18/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.